Who Buys Vancomycin from India — 743 Importers Behind a $92.2M Market
India's vancomycin import market is served by 743 active buyers who collectively imported $92.2M across 3,071 shipments. MYLAN INSTITUTIONAL INC 2898 (UNITED STATES) leads with a 11.4% market share, followed by MYLAN INSTITUTIONAL INC and EVERSANA. The top 5 buyers together control 33.5% of total import value, reflecting a moderately competitive buyer landscape.
Top Vancomycin Importers — Ranked by Import Value
MYLAN INSTITUTIONAL INC 2898 (UNITED STATES) is the leading vancomycin importer from India, holding a 11.4% share of the $92.2M market across 3,071 shipments from 743 buyers. The top 5 buyers — MYLAN INSTITUTIONAL INC 2898 (UNITED STATES), MYLAN INSTITUTIONAL INC (UNITED STATES), EVERSANA (UNITED STATES), EUGIA US LLC, (UNITED STATES), DR.FRIEDRICH EBERTH ARZNEIMITTEL (GERMANY) — collectively control 33.5% of total import value.
Top Vancomycin Buyers & Importers
Ranked by import value · 743 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | MYLAN INSTITUTIONAL INC 2898UNITED STATES VANCOMYCIN HYDROCHLORIDE FOR INJECTION UVANCOMYCIN HCL FOR INJECTION USP 10G/VIAL,100ML VIALVANCOMYCIN VIATRIS FOI 1G 1S MYLAN AUSTR | $10.5M | 5 | 11.4% |
| 2 | MYLAN INSTITUTIONAL INCUNITED STATES VANCOMYCIN HYDROCHLORIDE FOR INJECTION UVANCOMYCIN HCL FOR INJECTION USP 10G/VIAL,100ML VIALVANCOMYCIN VIATRIS FOI 1G 1S MYLAN AUSTR | $7.1M | 5 | 7.7% |
| 3 | EVERSANAUNITED STATES VANCOMYCIN HYDROCHLORIDE FOR INJECTION UVANCOMYCIN HCL FOR INJECTION USP 10G/VIAL,100ML VIAL | $6.6M | 5 | 7.2% |
| 4 | EUGIA US LLC,UNITED STATES VANCOMYCIN HYDROCHLORIDE FOR INJECTION UVANCOMYCIN HCL FOR INJECTION USP 10G/VIAL,100ML VIAL | $3.4M | 5 | 3.7% |
| 5 | DR.FRIEDRICH EBERTH ARZNEIMITTELGERMANY VANCOMYCIN DR. EBERTH 1000MG (VANCOMYCINVANCOMYCIN DR. EBERTH 500MG (VANCOMYCINVANCOMYCIN DR.EBERTH 250MG HARTKAPSELN | $3.3M | 5 | 3.6% |
| 6 | MYLAN INSTITUTIONAL, INCUNITED STATES VANCOMYCIN HYDROCHLORIDE FOR INJECTION UVANCOMYCIN HCL FOR INJECTION USP 10G/VIAL,100ML VIALVANCOMYCIN VIATRIS FOI 1G 1S MYLAN AUSTR | $3.0M | 5 | 3.2% |
| 7 | EUGIA US LLCUNITED STATES VANCOMYCIN HYDROCHLORIDE FOR INJECTION UVANCOMYCIN HCL FOR INJECTION USP 10G/VIAL,100ML VIAL | $2.9M | 5 | 3.2% |
| 8 | HANSE SERVICE INTERNATIONALEGERMANY VANCOMYCIN DR. EBERTH 1000MG (VANCOMYCINVANCOMYCIN DR. EBERTH 500MG (VANCOMYCINVANCOMYCIN DR.EBERTH 250MG HARTKAPSELN | $2.8M | 5 | 3.0% |
| 9 | MYLAN AUSTRALIAAUSTRALIA VANCOMYCIN HYDROCHLORIDE FOR INJECTION UVANCOMYCIN HCL FOR INJECTION USP 10G/VIAL,100ML VIALVANCOMYCIN VIATRIS FOI 1G 1S MYLAN AUSTR | $2.8M | 5 | 3.0% |
| 10 | EVERSANA EVERSANAUNITED STATES VANCOMYCIN HYDROCHLORIDE FOR INJECTION UVANCOMYCIN HCL FOR INJECTION USP 10G/VIAL,100ML VIAL | $2.4M | 5 | 2.6% |
| 11 | ALMAJECT INCUNITED STATES VANCOMYCIN HYDROCHLORIDE FOR INJECTION UVANCOMYCIN HCL FOR INJECTION USP 10G/VIAL,100ML VIAL | $2.3M | 5 | 2.5% |
| 12 | STRIDES NORDIC APSDENMARK VANCOMYCIN HYDROCHLORIDE CAPSULES 125 MGVANCOCIN VANCOMYCIN HYDROCHLORIDE CAPSULVANCOMYCIN HYDROCHLORIDE CAPSULES USP(12 | $2.1M | 5 | 2.3% |
| 13 | M/S.MYLAN INSTITUTIONAL INCUNITED STATES | $1.2M | 5 | 1.4% |
| 14 | INTEGRATED COMMERCIALIZATIONUNITED STATES VANCOMYCIN HYDROCHLORIDE FOR INJECTION UVANCOMYCIN HCL FOR INJECTION USP 10G/VIAL,100ML VIAL | $1.2M | 5 | 1.3% |
| 15 | SAUDI AMAROX FOR INDUSTRYSAUDI ARABIA VANIN VANCOMYCIN INJECTION INJVANCOMYCIN INJECTION INJVANIN VANCOMYCIN INJECTION 500MG INJ | $1.2M | 5 | 1.3% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Vancomycin — and from which countries?
Flow of Vancomycin exports from India: each country's share and the named importers behind the numbers
Vancomycin — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $50.6M through 381 shipments. This represents a market share of 54.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• MYLAN INSTITUTIONAL INC 2898 - $10.5M (20.7% of country's total business)
• MYLAN INSTITUTIONAL INC - $7.1M (14.0% of country's total business)
• EVERSANA - $6.6M (13.1% of country's total business)
• EUGIA US LLC, - $3.4M (6.8% of country's total business)
• MYLAN INSTITUTIONAL, INC - $3.0M (5.9% of country's total business)
• Rest of United States's importers - $20.0M (39.5% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $132.7K, indicating premium pricing strategy compared to the market average of $30.0K.
United States is a key market for Vancomycin imports, representing 54.8% of total trade value.
2Germany
Germany emerges as the second largest importing country, achieving a total trade value of $8.1M through 103 shipments. This represents a market share of 8.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Germany has a diverse importer base, with their top importers including:
• DR.FRIEDRICH EBERTH ARZNEIMITTEL - $3.3M (40.3% of country's total business)
• HANSE SERVICE INTERNATIONALE - $2.8M (34.6% of country's total business)
Key Insight: Germany demonstrates strong market positioning with an average shipment value of $78.9K, indicating premium pricing strategy compared to the market average of $30.0K.
Germany is a key market for Vancomycin imports, representing 8.8% of total trade value.
3Australia
Australia emerges as the third largest importing country, achieving a total trade value of $4.4M through 70 shipments. This represents a market share of 4.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Australia has a diverse importer base, with their top importers including:
• MYLAN AUSTRALIA - $2.8M (63.3% of country's total business)
• ASPEN PHARMACARE PTY LTD, - $916.1K (20.8% of country's total business)
Key Insight: Australia demonstrates strong market positioning with an average shipment value of $63.0K, indicating premium pricing strategy compared to the market average of $30.0K.
Australia is a key market for Vancomycin imports, representing 4.8% of total trade value.
4Saudi Arabia
Saudi Arabia emerges as the fourth largest importing country, achieving a total trade value of $2.7M through 11 shipments. This represents a market share of 2.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Saudi Arabia has a diverse importer base, with their top importers including:
• SAUDI AMAROX FOR INDUSTRY - $1.2M (42.5% of country's total business)
Key Insight: Saudi Arabia demonstrates strong market positioning with an average shipment value of $246.6K, indicating premium pricing strategy compared to the market average of $30.0K.
Saudi Arabia is a key market for Vancomycin imports, representing 2.9% of total trade value.
5Ethiopia
Ethiopia emerges as the fifth largest importing country, achieving a total trade value of $2.6M through 0 shipments. This represents a market share of 2.9% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Ethiopia demonstrates strong market positioning with an average shipment value of $2.6M, indicating premium pricing strategy compared to the market average of $30.0K.
Ethiopia is a key market for Vancomycin imports, representing 2.9% of total trade value.
Buyer Segment Analysis
TransData Nexus Vancomycin buyer market intelligence
1Buyer Segment Analysis
The 743 buyers of Vancomycin from India can be categorized into several segments:
1. Distributors: Entities like EVERSANA (United States, $6.61M) and HANSE SERVICE INTERNATIONALE (Germany, $2.81M) fall into this category. These organizations purchase large quantities to supply hospitals, pharmacies, and healthcare providers. Their buying behavior is characterized by bulk orders and regular procurement cycles to maintain consistent supply chains.
2. Hospital Groups: While specific hospital groups are not listed among the top buyers, such entities typically procure Vancomycin directly to meet patient needs. Their orders are substantial and aligned with patient admission rates and treatment protocols.
3. Retail Chains: Retail pharmacy chains may also import Vancomycin to stock their outlets. Their purchasing patterns are influenced by consumer demand and prescription trends, leading to moderate-sized, periodic orders.
4. Government Procurement: Organizations like UNICEF and the Global Fund, along with national health departments, procure Vancomycin for public health initiatives. Their procurement is often through large-scale tenders, focusing on cost-effectiveness and broad distribution.
5. Re-exporters: Companies such as MYLAN AUSTRALIA (Australia, $2.79M) may act as re-exporters, importing Vancomycin from India to distribute in other markets. Their buying behavior includes large orders intended for redistribution.
6. Contract Manufacturers: Entities like EUGIA US LLC (United States, $3.43M) may import Vancomycin as raw material for further processing or formulation. Their procurement is based on production schedules and client demands.
Country-Specific Import Regulations
TransData Nexus Vancomycin buyer market intelligence
1Country-Specific Import Regulations
United States
1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).
2. Import Registration Process: Importers must ensure that Vancomycin is FDA-approved. This involves submitting a New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) for generic versions.
3. Estimated Timeline for Registration: The NDA process can take 6-10 months, while the ANDA process may take 8-10 months.
4. Import Tariff/Duty for HS 30042096: Pharmaceutical products under this HS code are generally duty-free in the U.S.
Germany
1. Drug Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).
2. Import Registration Process: Requires a Marketing Authorization Application (MAA) submission to BfArM, including comprehensive data on quality, safety, and efficacy.
3. Estimated Timeline for Registration: Approximately 7-12 months.
4. Import Tariff/Duty for HS 30042096: As an EU member, Germany applies a 0% duty rate on pharmaceutical products under this HS code.
Australia
1. Drug Regulatory Authority: Therapeutic Goods Administration (TGA).
2. Import Registration Process: Requires inclusion in the Australian Register of Therapeutic Goods (ARTG), involving submission of detailed dossiers.
3. Estimated Timeline for Registration: Typically 6-12 months.
4. Import Tariff/Duty for HS 30042096: Generally duty-free under Australia's tariff schedule.
Saudi Arabia
1. Drug Regulatory Authority: Saudi Food and Drug Authority (SFDA).
2. Import Registration Process: Requires product registration with SFDA, including submission of technical documents and samples.
3. Estimated Timeline for Registration: Approximately 6-9 months.
4. Import Tariff/Duty for HS 30042096: Pharmaceutical products are typically exempt from import duties in Saudi Arabia.
Ethiopia
1. Drug Regulatory Authority: Ethiopian Food and Drug Authority (EFDA).
2. Import Registration Process: Requires product registration with EFDA, including submission of dossiers and compliance with national standards.
3. Estimated Timeline for Registration: Approximately 6-12 months.
4. Import Tariff/Duty for HS 30042096: Pharmaceutical products are generally exempt from import duties in Ethiopia.
Demand Drivers & Market Opportunity
TransData Nexus Vancomycin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Vancomycin is primarily driven by the prevalence of severe bacterial infections, including methicillin-resistant *Staphylococcus aureus* (MRSA) and other Gram-positive infections. The inclusion of Vancomycin in the WHO Essential Medicines List underscores its critical role in treating such infections, facilitating its procurement through national healthcare systems and international health organizations. (who.int)
Government healthcare programs and the expansion of universal health coverage in various countries have increased access to essential antibiotics like Vancomycin. Tender-based purchasing mechanisms, often employed by public health agencies, ensure a steady demand for Vancomycin, as these entities prioritize cost-effective procurement of essential medicines to meet public health needs. (cdn.who.int)
Common Questions — Vancomycin Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest vancomycin buyer importing from India?
Based on import volume and value, MYLAN INSTITUTIONAL INC 2898 (UNITED STATES) leads with $10.5M in imports and a 11.4% market share — the highest of any single vancomycin importer. MYLAN INSTITUTIONAL INC (UNITED STATES) and EVERSANA (UNITED STATES) are the next largest buyers.
QHow many companies buy vancomycin from India?
There are 743 active vancomycin buyers importing from India, with a combined market of $92.2M across 3,071 shipments to 140 countries. The top 5 buyers hold 33.5% of total import value, while the remaining 738 buyers handle the other 66.5%.
QWhich countries import the most vancomycin from India?
The top importing countries for vancomycin from India are United States (54.8%), Germany (8.8%), Australia (4.8%), Saudi Arabia (2.9%), Ethiopia (2.9%). These markets represent the largest demand centres for Indian pharmaceutical exports of vancomycin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for vancomycin from India?
The average import transaction value for vancomycin from India is $30.0K, with an average unit price of $50.05 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Vancomycin buyer market intelligence
1Buyer Segment Analysis
The 743 buyers of Vancomycin from India can be categorized into several segments:
1. Distributors: Entities like EVERSANA (United States, $6.61M) and HANSE SERVICE INTERNATIONALE (Germany, $2.81M) fall into this category. These organizations purchase large quantities to supply hospitals, pharmacies, and healthcare providers. Their buying behavior is characterized by bulk orders and regular procurement cycles to maintain consistent supply chains.
2. Hospital Groups: While specific hospital groups are not listed among the top buyers, such entities typically procure Vancomycin directly to meet patient needs. Their orders are substantial and aligned with patient admission rates and treatment protocols.
3. Retail Chains: Retail pharmacy chains may also import Vancomycin to stock their outlets. Their purchasing patterns are influenced by consumer demand and prescription trends, leading to moderate-sized, periodic orders.
4. Government Procurement: Organizations like UNICEF and the Global Fund, along with national health departments, procure Vancomycin for public health initiatives. Their procurement is often through large-scale tenders, focusing on cost-effectiveness and broad distribution.
5. Re-exporters: Companies such as MYLAN AUSTRALIA (Australia, $2.79M) may act as re-exporters, importing Vancomycin from India to distribute in other markets. Their buying behavior includes large orders intended for redistribution.
6. Contract Manufacturers: Entities like EUGIA US LLC (United States, $3.43M) may import Vancomycin as raw material for further processing or formulation. Their procurement is based on production schedules and client demands.
Country-Specific Import Regulations
TransData Nexus Vancomycin buyer market intelligence
1Country-Specific Import Regulations
United States
1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).
2. Import Registration Process: Importers must ensure that Vancomycin is FDA-approved. This involves submitting a New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) for generic versions.
3. Estimated Timeline for Registration: The NDA process can take 6-10 months, while the ANDA process may take 8-10 months.
4. Import Tariff/Duty for HS 30042096: Pharmaceutical products under this HS code are generally duty-free in the U.S.
Germany
1. Drug Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).
2. Import Registration Process: Requires a Marketing Authorization Application (MAA) submission to BfArM, including comprehensive data on quality, safety, and efficacy.
3. Estimated Timeline for Registration: Approximately 7-12 months.
4. Import Tariff/Duty for HS 30042096: As an EU member, Germany applies a 0% duty rate on pharmaceutical products under this HS code.
Australia
1. Drug Regulatory Authority: Therapeutic Goods Administration (TGA).
2. Import Registration Process: Requires inclusion in the Australian Register of Therapeutic Goods (ARTG), involving submission of detailed dossiers.
3. Estimated Timeline for Registration: Typically 6-12 months.
4. Import Tariff/Duty for HS 30042096: Generally duty-free under Australia's tariff schedule.
Saudi Arabia
1. Drug Regulatory Authority: Saudi Food and Drug Authority (SFDA).
2. Import Registration Process: Requires product registration with SFDA, including submission of technical documents and samples.
3. Estimated Timeline for Registration: Approximately 6-9 months.
4. Import Tariff/Duty for HS 30042096: Pharmaceutical products are typically exempt from import duties in Saudi Arabia.
Ethiopia
1. Drug Regulatory Authority: Ethiopian Food and Drug Authority (EFDA).
2. Import Registration Process: Requires product registration with EFDA, including submission of dossiers and compliance with national standards.
3. Estimated Timeline for Registration: Approximately 6-12 months.
4. Import Tariff/Duty for HS 30042096: Pharmaceutical products are generally exempt from import duties in Ethiopia.
Demand Drivers & Market Opportunity
TransData Nexus Vancomycin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Vancomycin is primarily driven by the prevalence of severe bacterial infections, including methicillin-resistant *Staphylococcus aureus* (MRSA) and other Gram-positive infections. The inclusion of Vancomycin in the WHO Essential Medicines List underscores its critical role in treating such infections, facilitating its procurement through national healthcare systems and international health organizations. (who.int)
Government healthcare programs and the expansion of universal health coverage in various countries have increased access to essential antibiotics like Vancomycin. Tender-based purchasing mechanisms, often employed by public health agencies, ensure a steady demand for Vancomycin, as these entities prioritize cost-effective procurement of essential medicines to meet public health needs. (cdn.who.int)
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 743 global importers of Vancomycin identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 3,071 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 140 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,071 Verified Shipments
743 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists